Clinical Trial Update: Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer

View source ↗

Summary

The trial evaluated quality of life in patients with primary or metastatic liver cancer treated with Yttrium-90 glass microsphere embolization. The study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Yttrium-90 glass microspheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Northwestern University | Conditions: Liver Cancer, Metastatic Cancer | Status: COMPLETED